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C. elegans insulin-like signaling regulates Results and discussion
Insulin signaling in C. elegans regulates the developmentalmetabolism, development, and life span. This
signaling pathway negatively regulates the activity decision to grow reproductively or arrest at the dauer
stage, and it affects metabolism, stress resistance, fertility,of the forkhead transcription factor DAF-16. daf-16
encodes multiple isoforms that are expressed in and life span. Because strong loss-of-function mutations
in daf-16 can suppress all of the phenotypes caused bydistinct tissue types and are probable orthologs of
human FKHRL1, FKHR, and AFX. We show that mutations in daf-2 insulin/IGF receptor tyrosine kinase
[2], temporally and spatially regulated expression of daf-16human FKHRL1 can partially replace DAF-16,
proving the orthology. In mammalian cells, insulin may be important to diversify the biological outputs of
insulin signaling. The daf-16 locus encodes three tran-and insulin-like growth factor signaling activate
AKT/PKB kinase to negatively regulate the nuclear scripts: a1, a2, and b, generated by alternative splicing
and probable alternative promoters [3]. The predictedlocalization of DAF-16 homologs (reviewed in [1]).
We show that the absence of AKT consensus sites protein products of daf-16a1 (DAF-16A1) and daf-16a2
(DAF-16A2) are closely related, differing by only twoon DAF-16 is sufficient to cause dauer arrest in
daf-2() animals, proving that daf-16 is the major amino acids, which is due to alternative splicing in exon
3. In contrast, daf-16a (refer to a1 and a2 together) andoutput of insulin signaling in C. elegans. FKHR,
FKRHL1, and AFX may similarly be the major outputs daf-16b share the C-terminal 319 amino acids encoded by
common exons but differ in their amino-terminal codingof mammalian insulin signaling. daf-2 insulin
signaling, via AKT kinases, negatively regulates regions; upstream from the common domain, DAF-16A1
(191 residues encoded by exon 1–4) and DAF-16B (211DAF-16 by controlling its nuclear localization.
Surprisingly, we find that daf-7 TGF- signaling also residues encoded by exon 5) are only 32% identical. The
5 ends of the daf-16a and daf-16b transcripts are separatedregulates DAF-16 nuclear localization specifically
at the time when the animal makes the commitment by 8.4 kb, strongly supporting distinct promoters and pos-
sibly distinct enhancers for each transcript. A 6.4-kb seg-between diapause and reproductive development.
daf-16 function is supported by the combined action ment from 5 to daf-16a directs expression in body wall
muscles, hypodermis, and intestine [3], whereas a 6.1-kbof two distinct promoter/enhancer elements,
whereas the coding sequences of two major DAF- segment from 5 to daf-16b directs expression in the phar-
ynx (S. Ogg and G.R., unpublished data). Thus, there16 isoforms are interchangeable. Together, these
observations suggest that the combined effects of may be distinct cis-regulatory regions that control the ex-
pression of each isoform. Because of their distinct expres-transcriptional and posttranslational regulation of
daf-16 transduce insulin-like signals in C. elegans sion patterns and N-terminal coding sequences, daf-16a
and daf-16b could mediate distinct functions.and perhaps more generally.
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Table 1
Dauer arrest phenotype of daf-16(x); daf-2(e1370) mutants.
X  Reproductive development Dauer(-like) arrest Other
mgDf47 96.5% (734) 0.1% (1) 3.4% (26)
mg54 92.3% (515) 0.2% (1) 7.5% (42)
m26 96.0% (1086) 2.1% (24) 1.9% (21)
 0% 75.5% (163) 24.5% (53)
Synchronized (within 3 hr) progeny of gravid mutant mothers were dauer features. The number of animals is in parentheses. Distributions
shifted to the test temperature (25C) for 46–52 hr. They were of arrested animals between the “dauer(-like)” and the “other”
then scored for the dauer arrest constitutive phenotype visually. For classes were somewhat variable from experiment to experiment.
all tables, reproductively developing animals included L4 and adult However, the combined percentage of the two classes was
animals. Dauer(-like) arrested animals were either complete or partial quantitatively reproducible for a given genotype. Strains used were:
dauers (showing one or more features, such as radial constriction, GR1309 for daf-16(mgDf47); daf-2(e1370), GR1308 for daf-
dauer alea, and pharyngeal constriction) or L2d animals. “Other” 16(mg54); daf-2(e1370), GR1117 for daf-16(m26); daf-2(e1370),
includes animals that were of L1, L2, or L3 stages that had no and GR1122 for daf-2(e1370).
notypes of a daf-2 mutant: daf-16(mgDf47); daf-2(e1370) suggests that daf-16a is a major target of C. elegans insulin
signaling. Alternatively, animals depend on the functiondouble mutant animals form virtually no dauers under
replete conditions at 25C, and the adults live even shorter of both daf-16a and daf-16b; the loss of either one may
be sufficient to abrogate daf-16 function. There is nothan wild-type ([5]; Table 1 and Figure 1). Under similar
conditions, few daf-16(mg54); daf-2(e1370) animals (1/558 daf-16b-specific lesion in our large collection of daf-16
mutant alleles (in addition to previously published dataassayed) or daf-16(m26); daf-2(e1370) animals (24/1131 as-
sayed) arrest at the dauer stage (Table 1). Similarly, nei- in [3] and [4], we sequenced exon 5 in 12 mutants; data
not shown), weakly supporting a model that daf-16b hasther daf-16(m26); daf-2(e1370) nor daf-16(mg54); daf-2
(e1370) animals lived longer than wild-type control ani- a less-central function in dauer arrest than daf-16a.
mals (Figure 1). Thus, daf-16a-specific mutations behave
similarly to daf-16(null) in their ability to suppress daf-2 We addressed the function of daf-16b using RNA interfer-
ence (RNAi; [7]). The daf-16a and daf-16b exons that(e1370). These results indicate that the daf-16b activity
that remains in these daf-16a probable null mutants is encode the distinct N-terminal regions are divergent
enough that double-stranded RNA corresponding tonot sufficient to supply daf-16 gene function.
daf-16b will not also target daf-16a (the longest uninter-
rupted run of nucleic acid identity is 5 base pairs betweenThe ability of a daf-16a mutation to fully suppress both
the aging and dauer arrest phenotypes of daf-2 strongly daf-16b-specific exon 5 used in RNAi and the entire
Figure 1
Adult life span of daf-16; daf-2 double
mutants. The life span of adult animals grown
at 25C presented as a Kaplan-Meier plot.
mgDf47 is a null allele of daf-16, whereas
mg54 and m26 are alleles that specifically
affect the daf-16a isoform [3]. Strains used
were: Bristol N2 for wild-type (n  592),
GR1309 for daf-16(mgDf47); daf-2(e1370)
(n  99), GR1308 for daf-16(mg54);
daf-2(e1370) (n  104), GR1117 for
daf-16(m26); daf-2(e1370) (n  68),
GR1122 for daf-2(e1370) (n  40), and
GR1329 for daf-16(mgDf47) (n  229). The
asterisk indicates that the daf-2(e1370) life
span was determined in slightly different
conditions than the rest, on regular rather
than FUdR-containing (fluorodeoxyuridine)
plates. FUdR does not affect the life span of
animals [20].
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Figure 2
GFP expression driven by a daf-16 enhancer/
promoter element. Fluorescent micrographs
of daf-16(mgDf47) animals that carry a
daf-16-rescuing translational GFP fusion
Ex[daf-16::GFP::DAF-16B] transgene. (a)
An L1 animal showing GFP expression in
neurons; four fluorescent neurons are marked
by arrowheads. (b) A late L4 animal. GFP
was expressed in the pharynx (marked by
triangles), somatic gonad (with an arrow
pointing to the vulva), and in neurons in the
tail (marked by an arrowhead). Transgene
array Ex[daf-16::GFP::DAF-16B] was made
as a complex extrachromosomal array in
order to get better stability of transgene
expression [21]. GR1329 daf-16(mgDf47)
animals were transformed with a mixture of
PvuII-digested worm genomic DNA (100 g/ 16B drastically reduced the viability of GFP vector. PCR primer sequences and
ml) and daf-16::GFP::DAF-16B minigene transgenic embryos (data not shown). DNA procedures for fusions are available at http://
(0.25 g/ml, in the form of PCR products). templates used: R13H8, a genomic cosmid whitney.caltech.edu/raymond/daf16.html or
Higher concentrations of daf-16::GFP::DAF- clone from A. Coulson, and pPD117.01, a upon request.
daf-16a1 transcript). RNAi experiments showed that inac- The daf-16 promoter element was defined by the 6.4-kb
(48–6408 bp in cosmid R13H8) genomic region 5 to thetivation of daf-16b in daf-2(e1370) had much weaker ef-
fects on dauer arrest than did the RNAi inactivation of daf- initiation ATG of daf-16a. We analyzed the expression
pattern of a daf-16-promoter::GFP::DAF-16B fusion16a alone: progeny of daf-2(e1370) animals that received
daf-16b dsRNA were 100% dauer arrest constitutive (44 of gene, which similarly rescues the dauer arrest-defective
phenotype of daf-16(mgDf47) (data not shown). GFP was44 animals), whereas progeny from mothers that received
daf-16a dsRNA (corresponding to exons 1–4) were 0% first detected in comma-stage embryos. After hatching,
transgenic animals showed high levels of GFP expressiondauer arrest constitutive (0 of 69 animals). The combina-
tion of daf-16a- and daf-16b-specific dsRNA was also ef- in almost all somatic cells. In contrast to the daf-16 fusion
gene, little GFPwas detected in somatic gonad or pharynxfective in suppressing daf-2(e1370) dauer arrest (1 of 75
progeny became a dauer; 74 developed reproductively). (except occasionally in one or two unidentified cells in
the terminal bulb; Figure 3 and data not shown).These results showed that daf-16a is the major genetic
activity from the daf-16 locus for daf-2-mediated dauer
arrest and longevity control. In order to validate the significance of these expression
patterns, we tested these fusion genes bearing full DAF-
16B protein-coding segments for the rescue of differentWhat makes daf-16a functionally different from daf-16b?
We first considered the possibility that the two isoforms aspects of the daf-16mutant phenotype. There are multi-
ple features of dauer larvae that differ from reproductivelyare differentially expressed. By transgenic rescue experi-
ments, we found that a 2-kb (12,727–14,813 bp in cosmid developing L3 larvae: a constricted pharynx, a shift to fat
storage, cuticular structures called dauer alae, as well asR13H8, accession number AF039717) genomic region im-
mediately 5 to the predicted first ATG codon of daf-16b resistance to stress and an increased life span. We found
that each of daf-16 and daf-16 promoter/enhancer DNAwas sufficient to direct expression of daf-16b-coding se-
quences to rescue the dauer arrest-defective phenotype segments can direct expression of DAF-16 proteins to
rescue some aspects of daf-16 loss-of-function mutantof daf-16(mgDf47) ([3] and see below). We named this
transcriptional regulatory element daf-16. We ana- phenotype, but their activities were partially comple-
mentary to each other (summarized in Table 2). daf-lyzed the cellular expression pattern of a daf-16-pro-
moter::GFP::DAF-16B fusion gene, in which GFP was 16(mgDf47) animals are partially dauer defective [8],
unable to form complete, SDS-resistant dauers under in-fused at the less well-conserved N terminus of DAF-
16B. This fusion gene rescues the dauer arrest defective ducing conditions (such as on starved plates), and they
have a shorter life span than wild-type ([5]; Figure 1 andphenotype of daf-16(mgDf47) (see below). We first de-
tected the functional GFP::DAF-16B fusion protein fluo- data not shown). We found that daf-16(mgDf47) trans-
genic animals bearing either daf-16::DAF-16A1 orrescence in early embryos, prior to morphogenesis. After
hatching and in all later developmental stages, transgenic daf-16::DAF-16B were able to form SDS-resistant dauer
larvae on starved plates. However, animals carryinglarvae showed GFP in the pharynx and in many neurons
throughout the body. From the late L3 stage onward, daf-16::DAF-16A1 formed dauers with little pharynx re-
modeling, which is normally found in dauer animals (0GFP was also detected in somatic gonads (Figure 2).
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Figure 3
DAF-16 protein nuclear localization is
dynamically regulated by daf-2 and daf-7.
Fluorescent micrographs of animals carrying
Ex[daf-16::GFP::DAF-16B], a daf-16/GFP
fusion gene that can rescue daf-16 mutant
dauer-defective phenotype (data not shown).
(a) An L1 animal of genotype
daf-16(mgDf47); daf-2(). GFP::DAF-16 is
mostly cytoplasmic, with a perinuclear
concentration. The soma of four neurons in
the head are marked by arrows. (b) An L1
animal of genotype daf-16(mgDf47);
daf-2(e1370). GFP::DAF-16 is prominently
nuclear localized. The nuclei of four neurons
in the head and two hypodermal cells in the
midbody are marked by arrows and triangles,
respectively. (c) The head region of a
daf-16(mgDf47); daf-7(m62) L2d predauer-
stage animal. GFP::DAF-16 was almost
exclusively localized in nuclei throughout the
animal. (d) The head region of a
daf-16(mgDf47); daf-7(m62) dauer animal
carrying the transgene showing a more diffuse,
primarily perinuclear GFP::DAF-16
localization. daf-16-promoter::GFP::DAF-
16B fusion PCR product (concentration at
2.5 ng/l) was mixed with 98 ng/l pRF4 [14]
rol-6 DNA and was used to transform
GR1329 daf-16(mgDf47) animals. The stably
transmitting transgene was then crossed into
daf-16(mgDf47); daf-2(e1370) and
daf-16(mgDf47); daf-7(m62) mutants.
of 30 SDS-resistant dauers examined had a constricted We also found a difference between the life span regula-
tory activity of the two fusion genes. daf-16(mgDf47);pharynx), whereas dauers that carried daf-16::DAF-16B
had more complete pharyngeal constriction (11 of 17 Ex[daf-16::DAF-16A1] transgenic animals had an aver-
age adult life span 65% longer that of control daf-dauers examined). This result is consistent with an auton-
omous DAF-16 protein function in the pharynx, because 16(mgDf47) animals, whereas Ex[daf-16::DAF-16B]
transgenic animals lived, on the average, only 14% longerthe daf-16 promoter element is active in the pharynx,
whereas daf-16 is not. than the control (Table 2).
Table 2
Comparisons of daf-16 and - promoter-driven fusion gene activity.
Phenotype in daf-16(mgDf47)Transgene
SDS-r Pha const. Mean lifespan (N)
Marker only 0/3 lines n/a 78% (40), 96% (39)a
daf-16::DAF-16A1 2/3 lines 0/30 dauers 165% (40)
daf-16::DAF-16B 2/3 lines 0/29 dauers 155% (40)
daf-16::DAF-16A1 3/3 lines 15/25 dauers 114% (40)
daf-16::DAF-16B 2/2 lines 11/17 dauers 114% (40)
SDS-r: presence of 1% SDS-resistant dauers on starved plates. 50 ng/l pRF4 and 50 ng/l pTG96 (expresses GFP in every
Each line is an independently generated transgenic strain. Pha nucleus, except, germ line [22]) plasmid DNA and were used to
const.: pharyngeal constriction in SDS-resistant dauers. Lifespan: transform GR1329 daf-16(mgDf47) animals. Transgenic lines were
mean adult lifespan measured at 25C, compared with daf- also made with markers only to serve as controls. DNA templates
16(mgDf47) without transgene. used in making PCR fuisions: R13H8, a genomic cosmid clone from
a Two independent lines showing different population lifespans. A. Coulson; pdaf16a1, a daf-16a1 cDNA clone described
daf-16-promoter::DAF-16A1, daf-16-promoter::DAF-16B, daf- previously [3]; pdaf16b, a cDNA clone isolated in this study that
16-promoter::DAF-16A1, and daf-16-promoter::DAF-16B fusion PCR contains the ORF part of AF020344 [3].
products (concentration at 2.5 ng/l) were each mixed with
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Given the fact that DAF-16A and DAF-16B proteins have centrations), the daf-16::DAF-16B fusion gene showed
100% arrest. However, most arrested animals bearingvery different sequences at their N termini, we tested if
the differences in coding sequences contribute to the daf-16::FKHRL1 showed no or partial dauer features,
such as body radial constrictions, dauer alae, and pharyn-difference in function of the fusion genes. By swapping
the protein-coding segments between the genes to gener- geal constrictions. We conclude that human FKHRL1 can
function like DAF-16 in mediating insulin signaling in C.ate daf-16::DAF-16B and daf-16::DAF-16A1 fusion
transgenes, we found that the protein-coding sequences elegans, but that its activity is weak.
were essentially interchangeable for life span and dauer
arrest regulation; no significant differences were detected Mammalian FKHRL1 is negatively regulated by AKT/
when comparing fusion genes with the same promoter PKB kinases [9]. C. elegans akt-1 and akt-2 have been
element but different coding sequences (Table 2). Thus, shown genetically to negatively regulate daf-16 [10]. On
at least in the context of these fusion genes, transcriptional DAF-16 (either the A or B form), there are four sites that
rather than protein sequence differences subserve the conform to the consensus of mammalian AKT phosphory-
particular biological functions of daf-16. lation. To address the biological importance of AKT phos-
phorylation, we assayed the phenotypic effects of express-
ing the AKT phosphorylation-defective DAF-16A1-4AOur genetic and fusion gene analyses indicate that daf-16a
mutant [11] in the daf-16(mgDf47) background. In theencodes the most important protein products of the daf-16
anticipation that transgenic animals might arrest constitu-locus and suggest that the distinction between the daf-16a
tively as dauers, we isolated the transgenic animals afterand daf-16b gene activities is likely based on their distinct
microinjection by feeding the injected parents and off-expression domains rather than the differences between
spring on Eschericia coli that express daf-16 dsRNA tothe DAF-16A and DAF-16B proteins (Figure 1 and Table
keep the DAF-16 expression levels low as lines were2). Although we did not compare the expression levels of
established [12]. Phenotype assays were then done on thethe daf-16 promoter fusion genes, the fusion genes were
decendents of those animals now feeding on non-daf-16injected at similar low-copy injection concentrations (2.5
RNAi E. coli for one generation or two.ng/l), and multiple transgenic lines were tested. We
therefore favor the model that the daf-16 promoter activ-
ity controls aging, whereas the daf-16 promoter activity is We found that daf-16(mgDf47) animals bearing the
necessary for pharyngeal restructuring during dauer arrest. daf-16::DAF16A1-4A fusion gene showed moderate
Both promoters contribute to dauer arrest. It may be that (60%) to nearly complete (99%) constitutive dauer or
daf-16 and daf-16 promoters supply combined trascrip- otherwise larval arrest under nondauer-inducing condi-
tional regulation more to daf-16a than to daf-16b to cause tions, depending on whether they were the first or second
dauer arrest and long life span. However, our transgenic generation progeny of animals that were fed daf-16
analyses may have exaggerated the role of daf-16 pro- dsRNA-expressing bacteria (Table 4). This result indi-
moter in dauer formation; chromosomal expression of cates that DAF-16 phosphorylation on some or all four
daf-16b alone may not be sufficiently high to significantly S/T residues by AKT (or other related) kinases is a crucial
effect dauer formation. Furthermore, we cannot rule out aspect of daf-16 gene function and a pivotal point of regu-
that expression of daf-16b is also affected in daf-16(mg54) lation. We could not measure the adult life span of these
and daf-16(m26) mutants. Further quantitative analyses transgenic animals because the variably penetrant arrest
of expressed RNA species in different genetic back- phenotype interfered with the isolation of a synchronized
grounds will resolve these issues. adult population. Because decrease in akt-1 and akt-2 gene
activity causes a similar phenotype to the inactivation of
AKT phosphorylation sites on DAF-16 [10], we favor theMammalian AFX, FKHR, and FKHRL1 are closely re-
model that AKT-1 and AKT-2 are the major inputs oflated in sequence to worm DAF-16. These mammalian
DAF-16 at these sites.genes are expressed in distinct tissue types and have
been implicated in insulin and insulin-like growth factor
signaling pathways (reviewed in [1]). To prove the or- In contrast to our findings, Lin et al. reported that a
daf-16A-4A mutant expressed from a transgene rescued athology between daf-16 and these related genes, we tested
the ability of human FKHRL1 to substitute for DAF-16 daf-16(null) mutant but did not cause any constitutive
dauer arrest or longevity phenotype in a daf-2() geneticin the functional fusion genes described above. We found
that a daf-16::FKHRL1 fusion gene supplies daf-16 gene background. They concluded that daf-2 regulates daf-16
via a non-AKT consensus site-based mechanism [13]. Weactivity to a daf-16(mgDf47); daf-2(e1370) double mutant
(Table 3). Under restrictive conditions, animals that car- consider three possibilities to reconcile the difference be-
tween their and our observations. First, the expressionried a daf-16::FKHRL1 fusion gene showed significantly
higher levels (70%) of daf-2mutant-like dauer and early levels of the transgenes may be significantly different.
Since they did not use RNAi to inhibit any dauer arrestlarval arrest compared to the nontransgenic controls (3%).
Under similar conditions (except at lower injection con- phenotypes in the initial line generation by transforma-
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Table 3
Rescue of the daf-16(mgDf47); daf-2(e1370) dauer-defective phenotype by human FKHRL1.
Reproductive
Transgene development (N) Dauer(-like) arrest (N) L3/L2 (N) L1/egg (N)
No transgene control 97.2% (141) 0.7% (1) 1.4% (2) 0.7% (1)
daf-16::DAF-16B 0% 48% (12) 20% (5) 32% (8)
daf-16::FKHRL1(line #1) 29.0% (31) 31.8% (34) 1.9% (2) 37.4% (40)
daf-16::FKHRL1(line #2) 9.5% (8) 47.6% (40) 17.9% (15) 25.0% (21)
Animals were scored 51 hr after egglay, at 25C. The PCR product PCR involving human FKHRL1 was pHs-FKHRL1-HA, a HA-tagged
of daf-16-promoter::FKHRL1 (10 ng/l) was mixed with pRF4 human FKHRL1 cDNA plasmid, a gift from M.J. Anderson and
(45 ng/l) and pTG96 (45 ng/l) and was used to transform GR1309 K.C. Arden (AF032886, [23]).
daf-16(mgDf47); daf-2(e1370) animals. A template used in the
tion, it is possible that their transgenes were selected to easy to force expression of wild-type DAF-16 to a level
sufficient to cause a dauer arrest constitutive phenotype.express at lower levels. Indeed they reported transgene
toxicity (see Methods in [13]). Second, their construct
contains extensive daf-16 intronic sequences that are not The expression of mutant DAF-16 from the trans-
gene suffers from some limitations. First, expression ofpresent in our construct. For example, intron 5 contains
the  promoter element (this report). These sequences Ex[daf-16::DAF16A1-4A] is heavily selected against be-
cause of the arrest and lethality it causes. We could onlymay affect the temporal and spatial patterns of gene ex-
pression. Third, Lin et al. expressed a GFP fusion protein. maintain the stock by feeding them with daf-16 RNAi
bacteria. This RNAi treatment was not effective enoughIt may be that the GFP::DAF-16 fusion is function-
ally different from the native protein. We do not favor to completely shut down transgene expression (Table 4
and data not shown). Furthermore, there appears to bethe model that overexpression of daf-16::DAF16A1-4A
causes constitutive dauer arrest. Control transgenes that RNAi perdurance; the RNA interference of daf-16 took
more than one generation to wear off completely afterwere produced by the same injection concentration (2.5
ng/l) but that expressed the wild-type DAF-16A1 pro- transfer of animals from feeding RNAi bacteria (Table 4
and data not shown). Third, extrachromosomal transgenesteins did not induce dauer arrest (Table 4). We have
attempted to produce high levels of daf-16 expression tend to be lost duringmitotic divisions, causing mosaicism
and reducing overall expression [14]. This may explainusing a heat shock promoter construct. Transgenic ani-
mals carrying an integrated transgene of hsp16-2::DAF- why the daf-16::DAF16A1-4A transgenic animals failed
to precisely phenotype copy daf-2(null) mutant animals.16B arrested as partial or complete dauers only when
subjected to repeat, periodic heat shock throughout their
lives (unpublished data). This result argues that it is not Mammalian insulin and insulin-like signaling regulate
Table 4
Dauer arrest phenotype caused by AKT phosphorylation incompetent DAF-16.
Reproductive Dauer(-like)
Transgenea development (N) arrest (N) L3/L2 (N) L1/egg (N)
DAF-16(4A)b 1.1% (1) 25.8% (23) 58% (52) 14.6% (13)
No Transgene siblingsb 94.9% (74) 0% 3.8% (3) 1.3% (1)
DAF-16(4A)c 44.2% (76) 19.2% (33) 36.6% (63) n/c
DAF-16(WT) 94.0% (480) 0% 6% (33) n/c
Animals were reared at 25C and were scored 48.5–56 hr after animals with a mixture of 2.5 ng/l daf-16::DAF16A1-4A as a PCR
egglay. product, 46 ng/l pRF4, 34 ng/l pTG96, and 11 ng/l pPHgfp1
a All animals carried daf-16(mgDf47). n/c means we had not (expresses GFP in hypodermis [24]). Transgenic animals had to be
particularly counted that class. maintained with daf-16 RNAi E. coli. When grown on OP50 E.
b Grandparents had been fed with daf-16 dsRNA-expressing bacteria. coli, transgenic animals are selected against by their dauer arrest
c Parents had been fed with daf-16 dsRNA-expressing bacteria. phenotype. For feeding RNAi, a 970-bp PvuII/XhoI fragment
The DAF-16(WT) transgene was made by germline transformation common to all daf-16 isoforms was cloned into the SmaI site of
with the PCR-generaged chimeric construct daf-16::DAF-16A1 plasmid pPD129.36, between T7 polymerase sites. The resulting
(2.5 g/ml); DAF-16(4A) was made with daf-16::DAF-16A1-4A plasmid, pT7-daf16common-T7, was used to transform E. coli strain
(2.5 g/ml) mutant fusion construct. The 4A mutant contains for HT115(DE3) and to make a bacterial strain, RX99. Feeding RNAi
S/T to A mutations that would abolish all potential sites of AKT was performed on worm culture NG agar plates containing IPTG,
phosphorylation [11]. daf-16::DAF16A1-4A fusion transgenic ampicillin, and tetracyclin, as described by Timmons et al. [12].
animals were made by transforming GR1329 daf-16(mgDf47)
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DAF-16 homologous proteins by inhibiting nuclear im- granules in the intestine. In the middle of the L2d stage,
the animal becomes committed to enter the dauer stageport or activating nuclear export via AKT phosphorylation
(reviewed in [1]). To see if this regulation is conserved rather than the L3 stage [17]. At all other stages in the
daf-7 mutant, including in the dauer stage, GFP::DAF-in C. elegans, we assayed the subcellular localization of a
functional GFP::DAF-16B fusion gene (driven by daf-16 16 was largely excluded from the nucleus Figure 3d. This
observation suggests that nuclear localization of DAF-16promoter) in different daf-2 genetic backgrounds.
We found that, in daf-16(mgDf47); daf-2() animals, is an important effector in the DAF-7 TGF- signaling
pathway as well. Indeed, although daf-16; daf-7 doubleGFP::DAF-16B was predominantly cytoplasmic, with a
high concentration around the nucleus (Figure 3A). In mutants are dauer arrest constitutive, the dauers that re-
sult are nevertheless incomplete. They lack pharyngealcontrast, in a daf-16(mgDf47); daf-2(e1370) mutant back-
ground, where upstream insulin-like signaling is defec- constriction and form indistinct alae [8].
tive at 25C, GFP::DAF-16B was concentrated in the nu-
cleus (Figure 3B). This change in subcellular localization Our result indicates that the daf-7 TGF- signaling path-
of GFP::DAF-16 appeared from the embryonic stage way crosstalks with the insulin pathway at a point up-
through late adulthood. Therefore, our results indicate stream of DAF-16 nuclear localization. daf-7 TGF- sig-
that DAF-16 and its mammalian homologs are regulated naling could act anywhere in the insulin signaling
by similar mechanisms. These results are in agreement pathway, from the expression or secretion of any of the
with those reported by Lin et al. [13]. worm insulins to DAF-16 itself. For example, daf-7 could
cause a surge of ins-1 expression in the L2d stage, which,
Our results indicate that phosphorylation of DAF-16 on as an antagonist, would shut down the daf-2 pathway
all or some of the four S/T residues within AKTphosphor- [18]. Alternatively, in cultured mammalian cells, TGF-
ylation consensus sites is the major means by which insu- treatments lead to a rapid downregulation of PTEN tran-
lin-like signaling transduces to daf-16. Furthermore, our script accumulation [19]. A similar mechanism could oper-
results indicate that the absence of phosphorylation of ate in the worm: loss of daf-7 TGF- signaling may in-
these AKT consensus sites on DAF-16 is sufficient, inde- crease daf-18 PTEN expression at the L2d stage, causing
pendent of insulin signaling, to induce dauer arrest. This a reduction in insulin signaling and AKT-(1,2) kinase
proves that daf-16 is the major output of insulin signaling activity, to affect DAF-16 nuclear accumulation.We stress
in C. elegans and suggests that FKHR, FKRHL1, and AFX that whatever the mechanism connecting daf-7 to DAF-
may similarly be the major outputs of mammalian insulin 16 localization may be, it functions only at the L2d stage.
signaling. Our results also argue that the AKT signaling This explains why mutations in the TGF- pathway are
output of DAF-2, and perhaps the orthologous mamma- synergistic with those in the insulin pathway only in the
lian insulin-like receptor tyrosine kinases, is the key out- dauer formation, but not the longevity, phenotype.
put, rather than thewide range of other signaling pathways
that have been suggested by biochemical analyses. Given the conservation that has been observed between
worm and mammalian insulin signaling pathways, and
The daf-7 TGF- signaling pathway also regulates dauer given that mammalian GDF-8 (accession number
arrest (reviewed in [15]). Although mutations in the NM010834) and GDF-11 (accession number AF028337)
TGF- pathway can enhance the dauer arrest constitutive are candidate DAF-7 orthologs, it is possible that these
phenotype caused by reductions in daf-2 insulin-like sig- TGF- signals may also interact with insulin signaling in
naling, there is no evidence that demonstrates amechanis- mammals.
tic coupling between these two signaling pathways [3].
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